Skip to main content

. 1971 Jan;173(1):47–54. doi: 10.1097/00000658-197101000-00007

Immunotherapy for the patient with cancer.

L J Humphrey, W R Jewell, D R Murray, W O Griffen Jr

PMCID: PMC1397121 PMID: 5101147

Images in this article

Fig. 1.
on p.48

Fig. 2.
on p.49

Fig. 3.
on p.50

Fig. 4.
on p.50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BJORKLUND B., PAULSSON J. E. Studies of hemagglutination as as a means for assay of malignant and normal human tissue antigens. J Immunol. 1962 Dec;89:759–766. [PubMed] [Google Scholar]
GRAHAM J. B., GRAHAM R. M. Autogenous vaccine in cancer patients. Surg Gynecol Obstet. 1962 Jan;114:1–4. [PubMed] [Google Scholar]
Humphrey L. J., Lincoln P. M., Griffen W. O., Jr Immunologic response in patients with disseminated cancer. Ann Surg. 1968 Sep;168(3):374–381. doi: 10.1097/00000658-196809000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
Humphrey L. J., Murray D. R., Jewell W. R., Griffen W. O., Jr Antitumor antibody in sera of immunized patients. Surg Forum. 1969;20:118–120. [PubMed] [Google Scholar]
Jaffe B. M., Donegan W. L., Watson F., Spratt J. S., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed] [Google Scholar]
KARZON D. T., POLLOCK B. F., BARRON A. L. Phase variation in ECHO virus type 6. Virology. 1959 Dec;9:564–576. doi: 10.1016/0042-6822(59)90149-7. [DOI] [PubMed] [Google Scholar]
MELNICK J. L. Papova virus group. Science. 1962 Mar 30;135(3509):1128–1130. doi: 10.1126/science.135.3509.1128. [DOI] [PubMed] [Google Scholar]
MOORE A. E., RHOADS C. P., SOUTHAM C. M. Homotransplantation of human cell lines. Science. 1957 Jan 25;125(3239):158–160. doi: 10.1126/science.125.3239.158. [DOI] [PubMed] [Google Scholar]
Morton D. L., Malmgren R. A., Hall W. T., Schidlovsky G. Immunologic and virus studies with human sarcomas. Surgery. 1969 Jul;66(1):152–161. [PubMed] [Google Scholar]
Nadler S. H., Moore G. E. Immunotherapy of malignant disease. Arch Surg. 1969 Sep;99(3):376–381. doi: 10.1001/archsurg.1969.01340150084016. [DOI] [PubMed] [Google Scholar]
Romsdahl M. M., Cox I. S. Immunofluorescent studies of antibodies against human malignant melanoma. Surg Forum. 1969;20:126–128. [PubMed] [Google Scholar]
SABIN A. B., KOCH M. A. Evidence of continuous transmission of non-infectious SV 40 viral genome in most or all SV 40 hamster tumor cells. Proc Natl Acad Sci U S A. 1963 Mar 15;49:304–311. doi: 10.1073/pnas.49.3.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
SCANLON E. F., HAWKINS R. A., FOX W. W., SMITH W. S. FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT. Cancer. 1965 Jun;18:782–789. doi: 10.1002/1097-0142(196506)18:6<782::aid-cncr2820180616>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
SOUTHAM C. M., MOORE A. E. Induced immunity to cancer cell homografts in man. Ann N Y Acad Sci. 1958 Oct 7;73(3):635–653. doi: 10.1111/j.1749-6632.1959.tb40840.x. [DOI] [PubMed] [Google Scholar]
VOGT M., DULBECCO R. Studies on cells rendered neoplastic by polyoma virus: the problem of the presence of virus-related materials. Virology. 1962 Jan;16:41–51. doi: 10.1016/0042-6822(62)90200-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES